How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of pharyngeal electrical stimulation for neurogenic dysphagia

    Closed for comments This consultation ended on at   Request commenting lead permission

    Additional information considered by IPAC

    Professional experts' opinions

    Expert advice was sought from consultants who have been nominated or ratified by their professional Society or Royal College. The advice received is their individual opinion and is not intended to represent the view of the society. The advice provided by professional experts, in the form of the completed questionnaires, is normally published in full on the NICE website during public consultation, except in circumstances but not limited to, when comments are considered voluminous, or publication would be unlawful or inappropriate.

    Four professional expert questionnaires for pharyngeal electrical stimulation for neurogenic dysphagia were submitted and can be found on the NICE website.

    Patient commentators' opinions

    NICE received 6 completed questionnaires from people who had the procedure. Additionally, 3 people who had been treated at 2 separate centres with pharyngeal electrical stimulation for neurogenic dysphagia shared their experiences through NICE's public involvement programme.

    Company engagement

    A structured information request was sent to 1 company who manufactures a potentially relevant device for use in this procedure. NICE received 1 completed submission. This was considered by the IP team and any relevant points have been taken into consideration when preparing this overview.

    Issues for consideration by IPAC

    • The PhINEST Study (https://clinicaltrials.gov/ct2/show/NCT03840395) is currently ongoing. This is a prospective, multicentre, randomised, sham-controlled, single-blind (outcome assessor) study of PES for the treatment of oropharyngeal dysphagia after invasive mechanical ventilation in an ICU population. Expected recruitment is 360 people, estimated study end date is December 2022.

    • The PhEAST study (https://www.isrctn.com/ISRCTNISRCTN98886991) is currently ongoing. This is a prospective, multicentre, randomised, sham-controlled, open label study of PES for the treatment of post-stroke oropharyngeal dysphagia. Expected recruitment is 800 people, estimated study end date is July 2025.